ClinicalTrials.Veeva
Menu

Find clinical trials for Eczema in Indianapolis, IN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Atopic Dermatitis
Dermatitis
Pruritus
Food Hypersensitivity
Hidradenitis
Hidradenitis Suppurativa
Hypersensitivity

Eczema trials near Indianapolis, IN, USA:

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

This research study is being conducted to find out if the test medicine, abrocitinib, improves eczema and is safe for children 6 to \<12 yea...

Enrolling
Eczema
Drug: Abrocitinib
Other: Placebo

Phase 3

Pfizer
Pfizer

Indianapolis, Indiana, United States of America and 20 other locations

This 24-month study will assess the long-term safety and efficacy of liquid abrocitinib oral suspension with or without topical medications in childr...

Begins enrollment this month
Atopic Dermatitis
Drug: Abrocitinib

Phase 3

Pfizer
Pfizer

Indianapolis, Indiana, United States of America and 6 other locations

The goal of this clinical trial is to assess the safety, tolerability, and pharmacokinetics of ATTO-1310 in healthy adults, patients with atopic derm...

Enrolling
Atopic Eczema
Chronic Pruritus
Drug: ATTO-1310 Placebo
Drug: ATTO-1310

Phase 1

Attovia Therapeutics Inc

Plainfield, Indiana, United States and 13 other locations

Locations recently updated

This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.

Enrolling
Eczema
Atopic Dermatitis
Drug: ATI-045
Drug: Placebo

Phase 2

Aclaris Therapeutics
Aclaris Therapeutics

Indianapolis, Indiana, United States and 28 other locations

The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema ...

Enrolling
Atopic Dermatitis
Drug: Lebrikizumab

Phase 4

Lilly
Lilly

Indianapolis, Indiana, United States of America and 74 other locations

The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD.The secondary objectives of the s...

Active, not recruiting
Atopic Dermatitis
Drug: Dupilumab

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Plainfield, Indiana, United States and 83 other locations

The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...

Enrolling
Atopic Dermatitis
Drug: PF-07275315
Other: Placebo

Phase 2

Pfizer
Pfizer

Indianapolis, Indiana, United States of America and 98 other locations

B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...

Active, not recruiting
Dermatitis, Atopic
Drug: Abrocitinib 200 mg
Drug: Abrocitinib 100 mg

Phase 3

Pfizer
Pfizer

Indianapolis, Indiana, United States of America and 541 other locations

The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.

Active, not recruiting
Atopic Dermatitis
Other: Placebo
Drug: Rocatinlimab

Phase 3

Amgen
Amgen

Indianapolis, Indiana, United States of America and 555 other locations

The goal of this clinical trial is to learn if CGB-500 works to treat atopic dermatitis in participants ages 12 and older. The goal is also to learn...

Enrolling
Atopic Dermatitis (AD)
Drug: CGB-500 Ointment with 1% tofacitinib
Drug: Vehicle (placebo)

Phase 2

CAGE Bio

Plainfield, Indiana, United States and 16 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems